首页 | 本学科首页   官方微博 | 高级检索  
检索        

鼻用糖皮质激素治疗慢性鼻窦炎的鼻窦CT观察
引用本文:张罗,王成硕,韩德民,周兵,王向东,葛文彤,李银川,王彤.鼻用糖皮质激素治疗慢性鼻窦炎的鼻窦CT观察[J].中华耳鼻咽喉头颈外科杂志,2007,42(9):673-678.
作者姓名:张罗  王成硕  韩德民  周兵  王向东  葛文彤  李银川  王彤
作者单位:1. 首都医科大学附属北京同仁医院耳鼻咽喉头颈外科;北京市耳鼻咽喉科研究所,100730
2. 首都医科大学附属北京同仁医院耳鼻咽喉头颈外科,100730
基金项目:科技部“十五”国家科技攻关计划课题资助(2004BA720A19-01)
摘    要:目的采用影像学方法评价鼻用糖皮质激素治疗慢性鼻窦炎(不合并鼻息肉)的疗效。方法慢性鼻窦炎患者24例(42侧),其中青少年患者11例(20侧),平均(x^-±s,下同)年龄(11.8±3.2)岁;成年患者13例(22侧),平均(36.7±11.0)岁。患者接受鼻用糖皮质激素(布地奈德鼻喷雾剂)治疗,成年和青少年患者的药物剂量分别为256μg/d和128μg/d,平均疗程分别为(7.5±3.2)周和(7.0±3.4)周。采用Lund-Mackay评分方法,在治疗前后分别对患者鼻窦CT进行评分(Lund得分),同时记录患者主诉鼻部症状改善情况。结果①治疗后,成年患者的平均Lund得分为6.5±7.5,显著低于治疗前(12.2±5.7,t=3.82,P〈0.01);青少年患者的平均Lund得分治疗后为2.6±3.7,显著低于治疗前(10.3±5.7,t=5.08,P〈0.01)。成年患者中5例(38%)达到影像学治愈标准,好转7例(54%),无效1例(8%);青少年患者中8例(73%)达到影像学治愈标准,好转3例(27%),两组疗效差异无统计学意义(P〉0.05)。②鼻用糖皮质激素对成年慢性前组筛窦炎治愈率最高(47%),对慢性后组筛窦炎治愈率最低(38%);药物对青少年慢性前、后组筛窦炎和慢性蝶窦炎的疗效优于成年患者。③成年患者的主观疗效与治疗前Lund得分呈正相关关系(r=0.676.P〈0.05),即治疗前Lund得分越高,主观疗效越差。青少年患者的主观疗效,与治疗前Lund得分无相关关系(P〉0.05)。结论鼻用糖皮质激素可有效治疗慢性鼻窦炎,部分患者可以达到影像学上的治愈标准。

关 键 词:鼻窦炎  糖皮质激素类  体层摄影术  X线计算机
修稿时间:2006-12-05

CT evolution of nasal steroid management of chronic rhinosinusitis
ZHANG Luo,WANG Cheng-shuo,HAN De-min,ZHOU Bing,WANG Xiang-dong,GE Wen-tong,LI Yun-chuan,WANG Tong.CT evolution of nasal steroid management of chronic rhinosinusitis[J].Chinese JOurnal of Otorhinolaryngology Head and Neck Surgery,2007,42(9):673-678.
Authors:ZHANG Luo  WANG Cheng-shuo  HAN De-min  ZHOU Bing  WANG Xiang-dong  GE Wen-tong  LI Yun-chuan  WANG Tong
Institution:Department of Otorhinolaryngology Head and Neck Surgery, Affiliated Belting Tongren Hospital of Capital University of Medical Sciences, Beijing Institute of Otorhinolaryngology, Beijing 100730, China
Abstract:OBJECTIVE: To evaluate the efficacy of topical steroid treatment of nonpolypoid chronic sinusitis. METHODS: Two cohorts of adult and children with nonpolypoid chronic sinusitis were investigated. The first cohort consisted of 11 pediatric patients mean age, (11.8 +/- 3.2) years] with a mean Lund score of 10.3 +/- 5.7 (x +/- s). The second cohort consisted of 13 adult patients mean age, (36.7 +/- 11.0) years] with a mean Lund score of 12.2 +/- 5.7. The mean duration of the nasal budesonide (Rhinocort) treatment was (7.5 +/- 3.2) weeks for adult patients (256 microg/d) and (7.0 +/- 3.4) weeks for pediatric patients (128 microg/d). Each Lund score and the patient's assessment of nasal symptoms were evaluated after treatment. RESULTS: The average Lund score was significantly decreased to 6.5 -/+ 7.5 (t = 3.82, P < 0.01) in adult patients and to 2.6 +/- 3.7 (t = 5.08, P < 0.01) in pediatric patients after treatment. Thirty-eight percent of the adult patients and 73% of the pediatric patients were cured on CT images. The patient's self-assessment of efficacy was positively correlated with pretreatment Lund score in adult patients (r = 0.676, P < 0.05), but not so in pediatric patients. CONCLUSIONS: These findings demonstrate that most of patients with nonpolypoid chronic sinus did well with topical steroid treatment. Therefore, surgery was required in few patients.
Keywords:Sinusitis  Glucocorticoids  Tomography  X-rey computed
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号